In:
Cancer, Wiley, Vol. 126, No. 17 ( 2020-09), p. 3991-4001
Abstract:
Simultaneous 20‐day perioperative inhibition of β‐adrenergic and COX2 signaling in patients with colorectal cancer has a favorable impact on tumor biomarkers associated with metastatic progression. Our results suggest scientific, medical, and safety justifications to conduct large‐scale clinical trials, assessing long‐term cancer outcomes.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v126.17
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink